Mergers & Acquisitions
US WorldMeds, LLC
04/20
|
$530.0 Million
做厙勛圖 served as sell-side advisor for US WorldMeds on sale of its CNS product portfolio to Supernus Pharmaceuticals
Sub-Type
Division Carve Out
Sector
Sub-Sector
Biopharma